K Kompoliti

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. ncbi Association between antipsychotics and body mass index when treating patients with tics
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illionois 60612, USA
    J Child Adolesc Psychopharmacol 20:277-81. 2010
  2. ncbi Complementary and alternative medicine use in Gilles de la Tourette syndrome
    Katie Kompoliti
    Department of Neurological Sciences, Section of Movement Disorders, Rush University Medical Center, 1725 W Harrison Street, Suite 755, Chicago, Illinois 60612, USA
    Mov Disord 24:2015-9. 2009
  3. ncbi Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 21:248-52. 2006
  4. ncbi Estrogen and Parkinson's disease
    Katie Kompoliti
    Department of Neurological Sciences, Section of Movement Disorders, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL 60546, USA
    Front Biosci 8:s391-400. 2003
  5. ncbi Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
    K Kompoliti
    Department of Neurological Science, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Neurology 58:1418-22. 2002
  6. ncbi Menstrual-related changes in motoric function in women with Parkinson's disease
    K Kompoliti
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL, USA
    Neurology 55:1572-5. 2000
  7. ncbi Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease
    K Kompoliti
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL, USA
    Neurology 54:458-62. 2000
  8. ncbi Estrogen supplementation in the posthypoxic myoclonus rat model
    K Kompoliti
    Department of Neurological Sciences, Rush University, Chicago, Illinois 60612, USA
    Clin Neuropharmacol 24:58-61. 2001
  9. ncbi Clinical presentation and pharmacological therapy in corticobasal degeneration
    K Kompoliti
    Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 55:957-61. 1998
  10. ncbi Pharmacological therapy in progressive supranuclear palsy
    K Kompoliti
    Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 55:1099-102. 1998

Detail Information

Publications18

  1. ncbi Association between antipsychotics and body mass index when treating patients with tics
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illionois 60612, USA
    J Child Adolesc Psychopharmacol 20:277-81. 2010
    ..The objective of this study is to investigate the relationship between antipsychotic use and weight in tic patients and compare the effects of SGAs to first-generation (typical) antipsychotics (FGAs)...
  2. ncbi Complementary and alternative medicine use in Gilles de la Tourette syndrome
    Katie Kompoliti
    Department of Neurological Sciences, Section of Movement Disorders, Rush University Medical Center, 1725 W Harrison Street, Suite 755, Chicago, Illinois 60612, USA
    Mov Disord 24:2015-9. 2009
    ..CAM is commonly used in children and adults with TS, and often without the neurologist's knowledge. Physicians should inquire about CAM to understand the spectrum of interventions that patients with TS use...
  3. ncbi Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 21:248-52. 2006
    ..Overall, patient awareness of NL side effects is insufficient, and although past exposure to NLs enhances knowledge, it decreases concern...
  4. ncbi Estrogen and Parkinson's disease
    Katie Kompoliti
    Department of Neurological Sciences, Section of Movement Disorders, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL 60546, USA
    Front Biosci 8:s391-400. 2003
    ..Such clarifications may also guide recommendations on the use of postmenopausal hormonal replacement therapy in women with Parkinson's disease or those genetically at risk...
  5. ncbi Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
    K Kompoliti
    Department of Neurological Science, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Neurology 58:1418-22. 2002
    ..5 mg/d and 4.5 mg/d of PPX or placebo. Compared to men, women had greater LD bioavailability. PPX did not alter LD bioavailability, and PPX pharmacokinetics were equivalent in men and women...
  6. ncbi Menstrual-related changes in motoric function in women with Parkinson's disease
    K Kompoliti
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL, USA
    Neurology 55:1572-5. 2000
    ..Although PD severity fluctuated during the study period, there was no significant correlation between the objective or subjective measures of parkinsonism and estrogen and progesterone levels...
  7. ncbi Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease
    K Kompoliti
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL, USA
    Neurology 54:458-62. 2000
    ..To determine the effect of central dopaminergic stimulation with apomorphine on speech in PD...
  8. ncbi Estrogen supplementation in the posthypoxic myoclonus rat model
    K Kompoliti
    Department of Neurological Sciences, Rush University, Chicago, Illinois 60612, USA
    Clin Neuropharmacol 24:58-61. 2001
    ..Estrogen enhances and prolongs posthypoxic myoclonus, suggesting that female gender and estrogen status may play a pivotal role as a risk factor for human posthypoxic myoclonus...
  9. ncbi Clinical presentation and pharmacological therapy in corticobasal degeneration
    K Kompoliti
    Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 55:957-61. 1998
    ..To date, to our knowledge, there is no systematic presentation of treatment outcome in large series of patients clinically diagnosed as having corticobasal degeneration...
  10. ncbi Pharmacological therapy in progressive supranuclear palsy
    K Kompoliti
    Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 55:1099-102. 1998
    ..To our knowledge, previous reports on drug treatment in progressive supranuclear palsy have not evaluated autopsy-confirmed cases...
  11. ncbi Movement disorders in Kuru
    K Kompoliti
    Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, Illinois, USA
    Mov Disord 14:800-4. 1999
    ..To describe the gamut of movement disorders (MD) seen during the clinical course of kuru...
  12. ncbi Dopaminergic hypersensitivity in patients with Parkinson disease and migraine
    Esther Cubo
    Sanatorio del Rosario, Clinica de la Zarzuela, Department of Neurology, Madrid, Spain
    Clin Neuropharmacol 27:30-2. 2004
    ..These data support the hypothesis that migraine may be associated with dopaminergic hypersensitivity...
  13. ncbi Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 22:1630-3. 2007
    ..There were few surviving cells staining with chromogranin A. The absence of TH-staining cells in the transplant 16 years after surgery provides further evidence that adrenal medullary transplants do not survive in the long term...
  14. ncbi Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
    Clifford W Shults
    Department of Neurosciences, Mail Code 0662, University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0662, USA
    Arch Neurol 59:1541-50. 2002
    ..Parkinson disease (PD) is a degenerative neurological disorder for which no treatment has been shown to slow the progression...
  15. ncbi Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra
    Yaping Chu
    Department of Neurological Sciences, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA
    J Comp Neurol 450:203-14. 2002
    ..These data demonstrate that age-related decline of DA phenotypic markers is associated with down-regulation of Nurr1 expression in the SN...
  16. ncbi Camptocormia associated with focal myositis in multiple-system atrophy
    Nico J Diederich
    Department of Neuroscience, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg
    Mov Disord 21:390-4. 2006
    ..The therapeutic response was poor. Similarities with the dropped-head syndrome suggest that the muscle pathology may be either the primary cause of CC, a focal reaction to the CC posture, or a coincident syndrome of old age...
  17. ncbi Nurr1 in Parkinson's disease and related disorders
    Yaping Chu
    Department of Neurological Science, Rush University Medical Center, Chicago, Illinois 60612, USA
    J Comp Neurol 494:495-514. 2006
    ..These data demonstrate that Nurr1 deficiency in dopaminergic neurons is associated with the intracellular pathology in both synucleinopathies and tauopathies...
  18. ncbi Sialorrhea in Parkinson's disease: a review
    Kelvin L Chou
    Department of Clinical Neurosciences, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    Mov Disord 22:2306-13. 2007
    ..This article reviews current knowledge regarding the frequency, etiology, assessment, and treatment of sialorrhea in PD...